| TATDN1 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, etc. | H | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 30481109 | 2018 |
| TATDN1 | hepatocellular carcinoma | qPCR, Luciferase reporter assay | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31378885 | 2019 |
| TATDN1 | breast cancer | qPCR, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31298381 | 2019 |
| TATDN1 | non small cell lung cancer | microarray, qPCR, RNAi, Western blot, Flow cytometry assay etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 26943769 | 2016 |
| TATDN1 | Triple negative breast cancer | Cell proliferation assay;Cell transfection;Cell transfection;microarray;qPCR;RT-qPCR; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33192097 | 2020 |